Development of NR0B2 as a therapeutic target for the re-education of tumor associated myeloid cells.
Vidana Gamage HE, Albright ST, Smith AJ, Farmer R, Shahoei SH, Wang Y, Fink EC, Jacquin E, Weisser E, Bautista RO, Henn MA, Schane CP, Nelczyk AT, Ma L, Das Gupta A, Bendre SV, Nguyen T, Tiwari S, Krawczynska N, He S, Tjoanda E, Chen H, Sverdlov M, Gann PH, Boidot R, Vegran F, Fanning SW, Apetoh L, Hergenrother PJ, Nelson ER.
Vidana Gamage HE, et al. Among authors: nelczyk at.
Cancer Lett. 2024 Aug 10;597:217086. doi: 10.1016/j.canlet.2024.217086. Epub 2024 Jun 27.
Cancer Lett. 2024.
PMID: 38944231
Free article.